Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Xevinapant |
| Trade Name | |
| Synonyms | AT-406|SM-406|Debio1143|Debio-1143|Debio 1143 |
| Drug Descriptions |
Xevinapant (debio 1143) is a SMAC mimetic, which antagonizes Inhibitor of Apoptosis Protein (IAP) family proteins, resulting in increased tumor cell apoptosis, decreased tumor growth (PMID: 21443232), and may reverse immunosuppression (PMID: 30352911, PMID: 32758455). |
| DrugClasses | SMAC Mimetic 8 |
| CAS Registry Number | 1071992-99-8 |
| NCIT ID | C90574 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Avelumab + Xevinapant | Avelumab Xevinapant | 0 | 1 |
| Carboplatin + Paclitaxel + Xevinapant | Carboplatin Paclitaxel Xevinapant | 0 | 1 |
| Cetuximab + Xevinapant | Cetuximab Xevinapant | 0 | 1 |
| Cisplatin + Xevinapant | Cisplatin Xevinapant | 0 | 3 |
| Cytarabine + Daunorubicin + Xevinapant | Cytarabine Daunorubicin Xevinapant | 0 | 0 |
| Nivolumab + Xevinapant | Nivolumab Xevinapant | 0 | 1 |
| Pembrolizumab + Xevinapant | Pembrolizumab Xevinapant | 0 | 1 |
| Xevinapant | Xevinapant | 0 | 4 |